Welcome to ASCO Connection Discussion

LOGIN TO START A DISCUSSION
Filter by All Topics
Molecular Oncology Tumor Board
ASCO University
Oct 14, 2015 10:22 AM
Read more to answer the following questions: 1. In general, would you be more inclined to offer a targeted therapy regimen or an immune therapy regimen? 2. If a BRAF-targeted therapy approach is selected, what therapeutic options are the most appropriate? 3. If an immune-targeted therapy approach...
Practice
Joseph Kim, MD, MPH, MBA
Oct 09, 2015 8:57 AM
This article in JAMA titled, "Facilitating Quality Improvement - Pushing the Pendulum Back Toward Process Measures" caught my attention the other day. The author starts by reflecting on the ongoing debate: should we focus more...
Linus T. Chuang, MD
Sep 16, 2015 10:47 AM
Welcome to this discussion forum for the Uterine Cancer Tumor Boards. This course included discussion of a 60 year old woman underwent total hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy and omentectomy for her serous adenocarcinoma of the endometrium. Final...
Molecular Oncology Tumor Board
ASCO University
Sep 09, 2015 9:57 AM
Read more to answer the following questions: 1) What is the differential diagnosis of skin rashes that precede or accompany a diagnosis of acute myeloid leukemia?  What particular dermatological condition does this patient have?  How would you treat it? 2) What is the prognostic significance of the...

Pages

Tweets from ASCO

Tweets from Oncology Community